Literature DB >> 29779106

Modular Nanotransporter with P21 Fragment Inhibits DNA Repair after Bleomycin Treatment.

T R Kamaletdinova1, A A Rosenkranz1,2, A V Ulasov1, Y V Khramtsov1, A D Tsvetkova1,2, G P Georgiev1, A S Sobolev3,4.   

Abstract

Modular nanotransporter (MNT) with C-terminal fragment of the p21 protein was synthesized and characterized, and its effect on DNA lesions was studied. This p21 fragment in MNT can significantly inhibit DNA repair in A431 human carcinoma cells after bleomycin treatment.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29779106     DOI： 10.1134/S1607672918020114

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


  12 in total

1.  Targeting cancer cells by novel engineered modular transporters.

Authors:  Dinara G Gilyazova; Andrey A Rosenkranz; Pavel V Gulak; Vladimir G Lunin; Olga V Sergienko; Yuri V Khramtsov; Kirill N Timofeyev; Mikhail A Grin; Andrey F Mironov; Andrey B Rubin; Georgii P Georgiev; Alexander S Sobolev
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

2.  Characterization of new modular nanotransporters with albumin-binding domain.

Authors:  Yu V Khramtsov; A V Ulasov; A D Tsvetkova; A A Rosenkranz; G P Georgiev; A S Sobolev
Journal:  Dokl Biochem Biophys       Date:  2017-04-19       Impact factor: 0.788

3.  Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering.

Authors:  W Martinet; M W Knaapen; G R De Meyer; A G Herman; M M Kockx
Journal:  Circ Res       Date:  2001-04-13       Impact factor: 17.367

Review 4.  Transcription factors: Time to deliver.

Authors:  Alexey V Ulasov; Andrey A Rosenkranz; Alexander S Sobolev
Journal:  J Control Release       Date:  2017-11-04       Impact factor: 9.776

5.  Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At.

Authors:  Andrey A Rosenkranz; Ganesan Vaidyanathan; Oscar R Pozzi; Vladimir G Lunin; Michael R Zalutsky; Alexander S Sobolev
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-01       Impact factor: 7.038

Review 6.  Examination of the expanding pathways for the regulation of p21 expression and activity.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  Cell Signal       Date:  2010-01-25       Impact factor: 4.315

7.  p21 promotes error-free replication-coupled DNA double-strand break repair.

Authors:  Maurizio Mauro; Meghan A Rego; Rebecca A Boisvert; Fumiko Esashi; Francesca Cavallo; Maria Jasin; Niall G Howlett
Journal:  Nucleic Acids Res       Date:  2012-06-26       Impact factor: 16.971

8.  Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Natalia B Morozova; Maria S Vorontsova; Vasiliy M Petriev; Tatiana N Lupanova; Alexey V Ulasov; Michael R Zalutsky; Raisa I Yakubovskaya; Alexander S Sobolev
Journal:  Int J Nanomedicine       Date:  2017-01-10

Review 9.  The comet assay for DNA damage and repair: principles, applications, and limitations.

Authors:  Andrew R Collins
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.860

10.  Dexamethasone and 1,25-dihydroxyvitamin D3 reduce oxidative stress-related DNA damage in differentiating osteoblasts.

Authors:  Elzbieta Pawlowska; Daniel Wysokiński; Paulina Tokarz; Agnieszka Piastowska-Ciesielska; Joanna Szczepanska; Janusz Blasiak
Journal:  Int J Mol Sci       Date:  2014-09-19       Impact factor: 5.923
View more
  1 in total

1.  The Delivery of Biologically Active Agents into the Nuclei of Target Cells for the Purposes of Translational Medicine.

Authors:  A S Sobolev
Journal:  Acta Naturae       Date:  2020 Oct-Dec       Impact factor: 1.845
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.